Xbrane Biopharma

Major Shareholding Notification • Nov 27, 2023

Issuer Xbrane Biopharma AB

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument
Instrument	Aktier
Before the transaction

Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Sell
Date	24/11/2023
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	1,464,568
Directly held voting rights	0
Indirectly held voting rights	1,464,568
Percentage
Directly held shares	4.91295 %
Directly held voting rights	0 %

Indirectly held voting rights 4.91295 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	4.91295 %	1,464,568
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled	0.38653 %	115,225
Total	5.29948 %	1,579,793

Group total holdings

Voting rights 1,579,793 Percentage of voting rights 5.29948

Notes (other relevant informations according to law)

Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt har avyttrat de aktuella aktierna.

Published

27/11/2023 10:33

Contact

Name Marie Andersson

Email marie.andersson@avanza.se

*Source of information has chosen not to submit the data

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25